Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

113 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Establishment of human tumor xenografts in immunodeficient mice.
Morton CL, Houghton PJ. Morton CL, et al. Nat Protoc. 2007;2(2):247-50. doi: 10.1038/nprot.2007.25. Nat Protoc. 2007. PMID: 17406581
Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts.
Houghton JA, Williams LG, Loftin SK, Cheshire PJ, Morton CL, Houghton PJ, Dayan A, Jolivet J. Houghton JA, et al. Among authors: morton cl. Cancer Chemother Pharmacol. 1992;30(6):423-32. doi: 10.1007/BF00685592. Cancer Chemother Pharmacol. 1992. PMID: 1394798
Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11.
Danks MK, Morton CL, Pawlik CA, Potter PM. Danks MK, et al. Among authors: morton cl. Cancer Res. 1998 Jan 1;58(1):20-2. Cancer Res. 1998. PMID: 9426050
Potentiation of 5-fluorouracil-leucovorin activity by alpha2a-interferon in colon adenocarcinoma xenografts.
Houghton JA, Cheshire PJ, Morton CL, Stewart CF. Houghton JA, et al. Among authors: morton cl. Clin Cancer Res. 1995 Jan;1(1):33-40. Clin Cancer Res. 1995. PMID: 9815884
Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.
Danks MK, Morton CL, Krull EJ, Cheshire PJ, Richmond LB, Naeve CW, Pawlik CA, Houghton PJ, Potter PM. Danks MK, et al. Among authors: morton cl. Clin Cancer Res. 1999 Apr;5(4):917-24. Clin Cancer Res. 1999. PMID: 10213229
Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase.
Wierdl M, Morton CL, Weeks JK, Danks MK, Harris LC, Potter PM. Wierdl M, et al. Among authors: morton cl. Cancer Res. 2001 Jul 1;61(13):5078-82. Cancer Res. 2001. PMID: 11431344
Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients.
Wagner LM, Guichard SM, Burger RA, Morton CL, Straign CM, Ashmun RA, Harris LC, Houghton PJ, Potter PM, Danks MK. Wagner LM, et al. Among authors: morton cl. Cancer Res. 2002 Sep 1;62(17):5001-7. Cancer Res. 2002. PMID: 12208753
Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistance.
Wierdl M, Wall A, Morton CL, Sampath J, Danks MK, Schuetz JD, Potter PM. Wierdl M, et al. Among authors: morton cl. Mol Pharmacol. 2003 Aug;64(2):279-88. doi: 10.1124/mol.64.2.279. Mol Pharmacol. 2003. PMID: 12869632
Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice.
Morton CL, Iacono L, Hyatt JL, Taylor KR, Cheshire PJ, Houghton PJ, Danks MK, Stewart CF, Potter PM. Morton CL, et al. Cancer Chemother Pharmacol. 2005 Dec;56(6):629-36. doi: 10.1007/s00280-005-1027-y. Epub 2005 May 26. Cancer Chemother Pharmacol. 2005. PMID: 15918039
Evaluation of ABT-751 against childhood cancer models in vivo.
Morton CL, Favours EG, Mercer KS, Boltz CR, Crumpton JC, Tucker C, Billups CA, Houghton PJ. Morton CL, et al. Invest New Drugs. 2007 Aug;25(4):285-95. doi: 10.1007/s10637-007-9042-y. Epub 2007 Mar 24. Invest New Drugs. 2007. PMID: 17384918
113 results
Jump to page
Feedback